Abstract
To evaluate the diagnostic efficacy of transrectal ultrasound (TRUS)-guided biopsy of the prostatic fossa in men with biochemical relapse following radical retropubic prostatectomy (RP). Thirty patients, with detectable prostate specific antigen (PSA) and negative imaging for metastases after RP, were evaluated for local recurrence. All patients underwent TRUS-guided biopsies of the prostatic fossa, with at least six cores obtained. PSA and digital rectal examination (DRE) were correlated with biopsy results. Twelve patients (40%) were found with local recurrence. Sensitivities of TRUS and DRE were 75 and 50%, while specificities were 83 and 100%, respectively. Local recurrence was detected in 25% of the patients with PSA ≤ 1 ng/ml, and higher PSA levels were correlated with an increased positive biopsy rate. All patients with positive DRE had positive biopsy and positive TRUS as well. When both TRUS and DRE were positive it was more likely for the patient to have positive biopsy than when both TRUS and DRE were negative. TRUS-guided biopsy is an efficient tool in detecting local recurrence after RP and should be offered to all patients with biochemical relapse and absence of metastatic disease irrespective of the level of PSA.
Similar content being viewed by others
References
Connolly JA, Shinohara K, Presti JC Jr et al (1996) Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology 47:225–231
Epstein JI, Pizov G, Walsh PC (1993) Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 71:3582–3593
Forman JD, Meetze K, Pontes E et al (1997) Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level. J Urol 158:1436–1439
Fowler JE Jr, Brooks J, Pandey P et al (1995) Variable histology of anastomotic biopsies with detectable prostate specific antigen after radical prostatectomy. J Urol 153:1011–1014
Gerber GS, Thisted RA, Scardino PT et al (1996) Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA 276:615–619
Koppie TM, Grossfeld GD, Nudell DM et al (2001) Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy? J Urol 166:111–115
Lange PH, Lightner DJ, Medini E et al (1990) The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J Urol 144:927–932
Laufer M, Pound CR, Carducci MA et al (2000) Management of patients with rising prostate-specific antigen after radical prostatectomy. Urology 55:309–315
Lepor H, Chan S, Melamed J (1998) The role of bladder neck biopsy in men undergoing radical retropubic prostatectomy with preservation of the bladder neck. J Urol 160:2435–2439
Leventis AK, Shariat SF, Slawin KM (2001) Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. Radiology 219:432–439
Lightner DJ, Lange PH, Reddy PK et al (1990) Prostate specific antigen and local recurrence after radical prostatectomy. J Urol 144:921–926
Ornstein DK, Colberg JW, Virgo KS et al (1998) Evaluation and management of men whose radical prostatectomies failed: results of an international survey. Urology 52:1047–1054
Parra RO, Wolf RM, Huben RP (1990) The use of transrectal ultrasound in the detection and evaluation of local pelvic recurrence after a radical urological pelvic operation. J Urol 144:707–709
Partin AW, Kattan MW, Subong EN et al (1997) Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277:1445–1451
Partin AW, Pearson JD, Landis PK et al (1994) Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology 43:649–659
Partin AW, Pound CR, Clemens JQ et al (1993) Serum PSA after anatomic radical prostatectomy: the Johns Hopkins experience after 10 years. Urol Clin North Am 20:713–725
Pound CR, Partin AW, Epstein JI et al (1997) Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am 24:395–406
Rogers R, Grossfeld GD, Roach M 3rd et al (1998) Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy. J Urol 160:1748–1753
Saleem MD, Sanders H, El Naser MA et al (1998) Factors predicting cancer in biopsy of the prostatic fossa after radical prostatectomy. Urology 51:283–286
Scattoni V, Roscigno M, Raber M et al (2003) Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage. Eur Urol 44:407–414
Schild SE, Buskirk SJ, Wong WW et al (1996) The use of radiotherapy for patients with isolated elevation of serum prostate specific antigens following radical prostatectomy. J Urol 156:1725–1729
Shekarriz B, Upadhyay J, Wood DP Jr et al (1999) Vesicourethral anastomosis biopsy after radical prostatectomy: predictive value of prostate-specific antigen and pathologic stage. Urology 54:1044–1048
Vander Kooy MJ, Pisansky TM, Cha SS et al (1997) Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy. Urology 49:65–70
Wasserman NF, Kapoor DA, Hildebrandt WC et al (1992) Transrectal US in evaluation of patients after radical prostatectomy. Part I. Normal postoperative anatomy. Radiology 185:361–366
Wasserman NF, Kapoor DA, Hildebrandt WC et al (1992) Transrectal US in evaluation of patients after radical prostatectomy. Part II. Transrectal US and biopsy findings in the presence of residual and early recurrent prostatic cancer. Radiology 185:367–372
Wood DP Jr, Peretsman SJ, Seay TM (1995) Incidence of benign and malignant prostate tissue in biopsies of the bladder neck after a radical prostatectomy. J Urol 154:1443–1446
Zincke H, Oesterling JE, Blute ML et al (1994) Long term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 152:1850–1857
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Deliveliotis, C., Manousakas, T., Chrisofos, M. et al. Diagnostic efficacy of transrectal ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomy. World J Urol 25, 309–313 (2007). https://doi.org/10.1007/s00345-007-0167-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-007-0167-6